NB004

· Ningbo Newbay Technology Development Co., Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NB004, covering 2026-04-22 to 2026-04-22. Get the full timeline:

Most recent: Clinical Trial Update: A Study of NB004 as Monotherapy or Combination Therapy in Patients With Advanced Solid Tumors [Phase 1]